Skip to content
Screener

Kestra Medical Technologies KMTS Q3 2025 earnings

Reported March 17, 2026

Revenue$24.6MBeat by $1.7M
EPS-$0.61Miss by $0.01
Revenue estimate$22.9M
EPS estimate-$0.60

Next report

Dec 10, 2026 (in 2 months)
Revenue estimate$32.0M
EPS estimate-$0.61

Financials

Q3 2025

Income statement

See full
Revenue$15.1M+117%
Gross profit$6.5M+7,134%
Operating income-$20.6M+3.1%
Net income-$21.5M+8.6%
EPS (diluted)-$1.25+1.4%

Balance sheet

See full
Cash & equivalents$54.4M—

Cash flow

See full
Operating cash flow-$18.0M+0.3%
CapEx$4.1M+32.9%
Free cash flow-$22.1M-4.5%

Valuation & ratios

Profitability

See full
Gross margin33.6%—
Operating margin-160.4%—
Net margin-172.2%—
FCF margin-182.1%—

FAQ

When did Kestra Medical Technologies report Q3 2025 earnings?
Kestra Medical Technologies (KMTS) reported Q3 2025 earnings on March 17, 2026.
What were Kestra Medical Technologies's Q3 2025 revenue and EPS?
Kestra Medical Technologies reported revenue of $24.6M and eps of $-0.61 for Q3 2025.
Did Kestra Medical Technologies beat estimates in Q3 2025?
Revenue beat the consensus estimate of $22.9M by $1.7M. EPS missed the consensus estimate of $-0.60 by $0.01.
Where can I find Kestra Medical Technologies's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-110720) and the 10-Q periodic report (0000950170-25-055319) directly on SEC EDGAR. The filing index links above go to sec.gov.